Magnesium Orotate.

The pump that holds the cell's potassium gradient uses magnesium-ATP, and low magnesium status increases urinary potassium loss. Potassium intake alone cannot restore the gradient.

Both hydroxylation steps that activate vitamin D depend on magnesium-requiring enzymes. Raising vitamin D intake raises magnesium demand in turn.

B6 supports magnesium entry into cells and reduces how much is lost again.

Calcium and magnesium use overlapping intestinal transport, so a large single dose of one lowers absorption of the other. Spacing them across the day keeps both.

High zinc doses reduce magnesium balance in mineral balance work. Separating the doses removes the overlap.

Thiamine pyrophosphate enzymes such as transketolase carry magnesium in the active site. Thiamine performs only as well as magnesium status allows.

Creatine kinase acts on magnesium-ATP rather than free ATP, so magnesium sits inside the reaction creatine supports. Low magnesium status caps the phosphate shuttle.

Magnesium and taurine both act on membrane excitability, magnesium as the natural counter-ion at the NMDA channel and taurine as an osmolyte that stabilises intracellular calcium handling. The two are often carried in the same product, and magnesium taurate exists as a salt for that reason. This is a mechanistic overlap rather than a tested combination effect.

Glycine is the ligand in magnesium glycinate, and formulators frequently pair free glycine with an organic magnesium salt for the same reason they chelate it: a small amino acid carrier keeps the cation in solution across the gut pH range. Glycine has its own role as an inhibitory neurotransmitter and a collagen substrate. The pairing is formulation convention, not a demonstrated additive outcome.

Boron intake shifts urinary handling of magnesium and calcium in balance studies, so the two are commonly formulated together in mineral blends. The relevant reading is retention rather than absorption. Evidence here comes from small metabolic balance work, which measures a marker of mineral handling and not a clinical outcome.

Magnesium and manganese are both divalent cations that move through overlapping intestinal transporters, so a large single dose of one lowers the fractional uptake of the other taken at the same time. Separating the doses across the day removes most of the interaction. This is textbook mineral absorption behaviour, not a safety concern about the pair.

Non-heme iron and magnesium compete at the divalent cation transporter in the duodenum when both arrive as a concentrated bolus. Spacing the two by a couple of hours is standard practice in mineral formulation. The competition is about the fraction absorbed from that dose, not about total status over weeks.

Phosphate and magnesium form poorly soluble magnesium phosphate in the alkaline small intestine, which lowers the magnesium available for uptake from that meal. Phosphate-heavy foods and phosphate salt excipients both do this. Orotate keeps the cation in an organic complex, which reduces but does not remove the effect.

Fermentable fibres are metabolised to short-chain fatty acids in the colon, and the resulting drop in luminal pH keeps magnesium in a soluble ionised state where passive colonic uptake can occur. Human work on inulin-type fructans reports higher apparent mineral absorption, which is a balance marker rather than a clinical endpoint. The effect depends on the fibre actually being fermented.

Phytic acid from grains and legumes chelates magnesium in the gut lumen and carries it through unabsorbed. Phytase hydrolyses the phosphate groups off the inositol ring and releases the bound cation. The interaction matters most in plant-heavy meals and very little in a fasted dose.

Vitamin K2 drives the gamma-carboxylation of osteocalcin and matrix Gla protein, both of which govern where calcium is deposited, while magnesium supports normal bone mineral structure and is required for the enzyme that activates vitamin D. The two sit at different points of the same mineral-handling system. This is mechanistic complementarity, not a combination trial result.

Every ATP molecule is biologically active as an Mg-ATP complex, and coenzyme Q10 carries electrons between complex I or II and complex III of the same mitochondrial chain that generates it. Pairing them addresses two different requirements of normal cellular energy production. Neither substitutes for the other.

The orotate half of this salt is an intermediate of de novo pyrimidine synthesis, and ribose-5-phosphate supplies the PRPP that orotate condenses with to form the nucleotide. Magnesium is the cofactor for the kinases in that same route. The pairing is coherent on paper and has not been measured together as a supplement combination.

Magnesium modulates NMDA and GABA-A signalling while melatonin acts on MT1 and MT2 receptors to shift circadian timing, so evening products frequently carry both. Their calming effects can stack. Anyone taking sedating medication should regard the combination as additive and raise it with a clinician.

L-theanine raises alpha-band cortical activity and modulates glutamatergic tone, which overlaps with magnesium's role as the voltage-dependent block on the NMDA channel. Evening formulas pair them for that reason. The overlap is mechanistic and the combined effect has not been quantified.

Ascorbic acid lowers the pH of the gastric and upper intestinal environment and keeps divalent cations in a soluble form for longer, which is the same chemistry that improves non-heme iron uptake. For an organic magnesium salt the added benefit is small because the orotate ligand already does much of that work. Read this as plausible rather than measured.

Viscous soluble fibre traps divalent cations inside its gel and speeds transit, so a magnesium dose taken in the same mouthful is less available. The standard handling is to separate mineral doses from bulk fibre by two hours. The effect is on that dose, not on long-term magnesium status.

Activated charcoal adsorbs small charged molecules non-selectively, minerals included, and does not distinguish a supplement from anything else in the gut. Taking it near a magnesium dose lowers what is absorbed. Separate the two by several hours.

A high sodium load increases urinary magnesium loss through shared handling in the loop of Henle and distal tubule. The relationship shows up in metabolic balance studies as a change in excretion, which is a marker of renal handling rather than an outcome. It matters more for habitual intake than for a single dose.